INTU
65
-2
RRC
62
-6
APD
34
-5
PAYX
41
-3
LUV
48
-2
ACN
29
-2
FMC
39
-2
GPS
47
-3
EXPE
56
-3
AMT
56
5
QRVO
59
-22
AMP
69
3
ALL
53
3
MCK
64
-2
K
38
-3
RSG
67
-6
MMM
35
5
IFF
44
-3
HUM
36
2
MU
50
-4
INTU
65
-2
RRC
62
-6
APD
34
-5
PAYX
41
-3
LUV
48
-2
ACN
29
-2
FMC
39
-2
GPS
47
-3
EXPE
56
-3
AMT
56
5
QRVO
59
-22
AMP
69
3
ALL
53
3
MCK
64
-2
K
38
-3
RSG
67
-6
MMM
35
5
IFF
44
-3
HUM
36
2
MU
50
-4
Financhill
Back

PeptiDream 10K Form

Buy
90

PPTDF
PeptiDream

Last Price:
13.11
Seasonality Move:
-5.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PPTDF News And Ratings

See the #1 stock for the next 7 days that we like better than PPTDF

PPTDF Financial Statistics

Sales & Book Value

Annual Sales: $204.65M
Cash Flow: $21.3M
Price / Cash Flow: 21.6
Annual Sales: $2.21
Price / Book: 5.94

Profitability

EPS (TTM): 0.16000
Net Income (TTM): $20.76M
Gross Margin: $122.73M
Return on Equity: 8.41%
Return on Assets: 4.57%

PeptiDream Earnings Forecast

Key PeptiDream Financial Ratios

  • The Gross Profit Margin over the past 12 years for PPTDF is 59.97%.
  • The Selling, General & Administrative Expenses for PPTDF have been equal to 25.27% of Gross Profit Margin.
  • The Research & Development expenses have been 10.99% of Revenue.
  • The Interest Expense is 74.21% of Operating Income.
  • The Net Earning history of PPTDF is 10.57% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

PeptiDream Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: PPTDF
Website: peptidream.com

Debt

Debt-to-Equity Ratio: 0.55
Current Ratio: 3.16
Quick Ratio: 2.84

Price-to-Earnings

Trailing P/E Ratio: 78.67
Forward P/E Ratio: 0

PPTDF Technical Analysis vs Fundamental Analysis

Buy
90
PeptiDream (PPTDF) is a Buy

Is PeptiDream a Buy or a Sell?

  • PeptiDream stock is rated a Buy
    The current PeptiDream [PPTDF] share price is $13.11. The Score for PPTDF is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.